Rx to Go LLC, the in-house specialty pharmacy for Florida Cancer Specialists & Research Institute LLC (FCS), announced on Tuesday that it has received re-accreditation through Accreditation Commission for Health Care (ACHC) for pharmacy services with distinction in oncology through November 2028.
In the accreditation process, healthcare organisations must demonstrate compliance with national standards. Accreditation by ACHC reflects an organisation's dedication and commitment to meeting standards that facilitate a higher level of performance and patient care, Rx to Go said.
Rx To Go also has accreditation by URAC for Specialty Pharmacy and is dually accredited by the National Association of Boards of Pharmacy (NABP) for specialty pharmacy. FCS is also NABP accredited for digital pharmacy practice.
Natera submits Signatera CDx PMA to FDA for bladder cancer use
Astrazeneca Imfinzi perioperative regimen gains positive EU CHMP opinion in early gastric cancer
I Peace generates human iPS cells from NKT cells and offers them for research use
Frontage expands early phase clinical research capabilities across US and China
Summit Therapeutics' BLA for ivonescimab in EGFR-mutated NSCLC accepted by FDA
InSysBio agrees new collaborative project with BeOne Medicines
Physiomics secures new modelling contract with Numab Therapeutics
Mabwell reports first patient dosed with 7MW4911 in US trial
Atossa Therapeutics' founder and CEO named one of The Top 50 Healthcare Technology CEOs of 2025
Avacta secures FDA clearance for second pre|CISION oncology programme
Guardant Health and Merck enter multi-year oncology diagnostics collaboration
Akeso secures NMPA review acceptance for gumokimab in ankylosing spondylitis